ConductScience.org, home

Paper26319699

Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

MacColl E and 1 other. J Pharmacol Exp Ther, 2015. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease. Papers, record 26319699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26319699

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
2.81
iCite
Revised in PubMed
2025-03-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1MacColl EElisabeth
2Khalil RARaouf A

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Matrix MetalloproteinasesMajor topic
Vascular DiseasesMajor topic
VeinsMajor topic
Animals
Chronic Disease
Humans
Matrix Metalloproteinase Inhibitors
Tissue Distribution

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HL-65998NHLBI NIH HHSUnited StatesR01HL065998PubMed and NIHNIH RePORTER
R01 HL065998NHLBI NIH HHSUnited StatesR01HL065998PubMed and NIHNIH RePORTER
R21 HL111775NHLBI NIH HHSUnited StatesR21HL111775PubMed and NIHNIH RePORTER
R21 HL098724NHLBI NIH HHSUnited StatesR21HL098724PubMed and NIHNIH RePORTER
HL-111775NHLBI NIH HHSUnited StatesR21HL111775PubMed and NIHNIH RePORTER
HL-98724NHLBI NIH HHSUnited StatesR21HL098724PubMed and NIHNIH RePORTER

Download CSV of grants

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111555661Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.J Biol Chem2001https://conductscience.org/library/papers/11555661PubMed
219847861Pathogenesis of primary varicose veins.Br J Surg2009https://conductscience.org/library/papers/19847861PubMed
315762202Four-year follow-up on endovascular radiofrequency obliteration of great saphenous reflux.Dermatol Surg2005https://conductscience.org/library/papers/15762202PubMed
411790786Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases.J Biol Chem2002https://conductscience.org/library/papers/11790786PubMed
515558018CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.Oncogene2005https://conductscience.org/library/papers/15558018PubMed
615557917Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.J Vasc Surg2004https://conductscience.org/library/papers/15557917PubMed
713902219Collagenolytic activity in amphibian tissues: a tissue culture assay.Proc Natl Acad Sci U S A1962https://conductscience.org/library/papers/13902219PubMed
820598922Inhibitory effect of TIMP influences the morphology of varicose veins.Eur J Vasc Endovasc Surg2010https://conductscience.org/library/papers/20598922PubMed
917541420Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17541420PubMed
1016543495Endothelium-derived hyperpolarizing factor: where are we now?Arterioscler Thromb Vasc Biol2006https://conductscience.org/library/papers/16543495PubMed
1118502086Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins.J Vasc Surg2008https://conductscience.org/library/papers/18502086PubMed
128592422Biochemical assay of collagen and elastin in the normal and varicose vein wall.J Surg Res1996https://conductscience.org/library/papers/8592422PubMed
1321195432Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins.J Surg Res2011https://conductscience.org/library/papers/21195432PubMed
1423864155Platelets and matrix metalloproteinases.Thromb Haemost2013https://conductscience.org/library/papers/23864155PubMed
1521106323Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava.J Vasc Surg2011https://conductscience.org/library/papers/21106323PubMed
1611342575Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.J Clin Invest2001https://conductscience.org/library/papers/11342575PubMed
1711932671Endovenous treatment of the greater saphenous vein with a 940-nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser-generated steam bubbles.J Vasc Surg2002https://conductscience.org/library/papers/11932671PubMed
1817067977Conception of the venous hemodynamics in the lower extremity.Angiology2006https://conductscience.org/library/papers/17067977PubMed
1923840100Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.Mediators Inflamm2013https://conductscience.org/library/papers/23840100PubMed
2017979138Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathway.J Cell Biochem2008https://conductscience.org/library/papers/17979138PubMed

See all 134 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42941624Chronic Venous Disease in Pregnancy: Pathophysiology, Diagnostic Pitfalls, and a Trimester-Stratified Management Framework-A Narrative Review.J Clin Med2026https://conductscience.org/library/papers/42941624PubMed
41753340Pelvic Congestion Syndrome: The Gynecological Perspective.J Clin Med2026https://conductscience.org/library/papers/41753340PubMed
41348870A self-assembled nano micelle-exosome with high selectivity and penetrability achieves precise intracartilage lipid delivery.Sci Adv2025https://conductscience.org/library/papers/41348870PubMed
41089597Correlation Analysis of Lower Limb Venous Dilation in Patients With Diabetic Foot Ulcers.J Diabetes Res2025https://conductscience.org/library/papers/41089597PubMed
39897588A versatile platform based on matrix metalloproteinase-sensitive peptides for novel diagnostic and therapeutic strategies in arthritis.Bioact Mater2025https://conductscience.org/library/papers/39897588PubMed
39355120Mast cells: a double-edged sword in inflammation and fibrosis.Front Cell Dev Biol2024https://conductscience.org/library/papers/39355120PubMed
39132527Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review.J Soc Cardiovasc Angiogr Interv2023https://conductscience.org/library/papers/39132527PubMed
38928491Key Regulators of Angiogenesis and Inflammation Are Dysregulated in Patients with Varicose Veins.Int J Mol Sci2024https://conductscience.org/library/papers/38928491PubMed
38839285Vicious Circle With Venous Hypertension, Irregular Flow, Pathological Venous Wall Remodeling, and Valve Destruction in Chronic Venous Disease: A Review.Angiology2026https://conductscience.org/library/papers/38839285PubMed
38643908Increased uterine arterial tone, stiffness and remodeling with augmented matrix metalloproteinase-1 and -7 in uteroplacental ischemia-induced hypertensive pregnancy.Biochem Pharmacol2024https://conductscience.org/library/papers/38643908PubMed
37772751Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease.Expert Rev Cardiovasc Ther2023https://conductscience.org/library/papers/37772751PubMed
37372128Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions.Biology (Basel)2023https://conductscience.org/library/papers/37372128PubMed
37175078Outlook on Chronic Venous Disease Treatment: Phytochemical Screening, In Vitro Antioxidant Activity and In Silico Studies for Three Vegetal Extracts.Molecules2023https://conductscience.org/library/papers/37175078PubMed
36471437Advances in the development of tubular structures using extrusion-based 3D cell-printing technology for vascular tissue regenerative applications.Biomater Res2022https://conductscience.org/library/papers/36471437PubMed
36180575Differential expression of aqueous humor microRNAs in central retinal vein occlusion and its association with matrix metalloproteinases: a pilot study.Sci Rep2022https://conductscience.org/library/papers/36180575PubMed
35563387Novel Biomarkers of Atherosclerotic Vascular Disease-Latest Insights in the Research Field.Int J Mol Sci2022https://conductscience.org/library/papers/35563387PubMed
35371072Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis.Front Immunol2022https://conductscience.org/library/papers/35371072PubMed
35359676Use of ATP-Binding Cassette Subfamily A Member 13 (ABCA13) for Sensitive Detection of Focal Pathological Forms of Subclinical Bovine Paratuberculosis.Front Vet Sci2022https://conductscience.org/library/papers/35359676PubMed
34935563Comprehensive overview of the venous disorder known as pelvic congestion syndrome.Ann Med2022https://conductscience.org/library/papers/34935563PubMed
34600915TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.Biochem Pharmacol2021https://conductscience.org/library/papers/34600915PubMed

See all 43 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CMA11215PubTator's text mininghttps://conductscience.org/library/genes/1215NCBI Gene
ELN2006PubTator's text mininghttps://conductscience.org/library/genes/2006NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26319699

GET https://conductscience.org/api/papers/v1/26319699/references?page=2